Co-Authors
This is a "connection" page, showing publications co-authored by Lorenzo Piemonti and Gabriella Scarlatti.
Connection Strength
0.586
-
Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival. Nat Commun. 2021 05 11; 12(1):2670.
Score: 0.236
-
Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia. J Clin Endocrinol Metab. 2021 04 23; 106(5):1472-1481.
Score: 0.235
-
COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain. J Clin Invest. 2020 12 01; 130(12):6366-6378.
Score: 0.057
-
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report. Front Immunol. 2020; 11:603428.
Score: 0.057